Literature DB >> 9682341

Surveillance of suspected poliomyelitis in Albania, 1980-1995: suggestion of increased risk of vaccine associated poliomyelitis.

E Diamanti1, B Ibrahimi, F Tafaj, E Mezini, A Dodbiba, V Dobi, S Catone, D Genovese, P Simeoni, L Fiore.   

Abstract

Surveillance of suspected poliomyelitis cases was conducted in Albania from 1980 through 1995. A total of 93 cases were reported, 11 of which were clinically defined as poliomyelitis cases according to WHO criteria. Poliovirus was isolated from six subjects who were defined as contact vaccine-associated cases. Characterization of isolates by both antigenic and molecular methods showed that, in all cases, the disease was associated with type 2 or 3 polioviruses of vaccine origin with retromutations known to be associated with loss of Sabin attenuated phenotype. Infection occurred despite the fact that all patients had records of previous immunization with oral polio vaccine (OPV), suggesting a failure of vaccination. Four of the five patients from which poliovirus could not be isolated were classified as possible recipient vaccine-associated poliomyelitis on the basis of serology data (presence of antibodies against all three polioviruses) and the temporal association between the latest dose of vaccine received and onset of paralysis. Virological investigation on healthy contacts of the poliomyelitic patients yielded the isolation of a further 12 Sabin-like polio revertant viruses, mostly type 2 and 3. A detailed study of the non-polio acute flaccid paralysis (AFP) cases and their healthy contacts revealed the presence of several enteroviruses, namely Echo, coxsackie and, in three cases type 2 or 3 Sabin-like polioviruses. Overall, these data suggest the absence of circulation of wild-type poliovirus in Albania from 1980 to 1995, before the recent outbreak of poliomyelitis in 1996, and emphasize the need for active surveillance of AFP and laboratory characterization of virus isolates to monitor vaccination efficacy.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9682341     DOI: 10.1016/s0264-410x(98)80025-x

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  9 in total

1.  Serum antibodies to polioviruses in Alexandria, Egypt.

Authors:  R Gabrieli; M Divizia; E El Ghazzawi; O A Kader; Z El Gawhary; E Renganathan; A Panà
Journal:  Eur J Epidemiol       Date:  1999-03       Impact factor: 8.082

2.  Investigation of the presence of recombinant polioviruses in the hit population in Albania during the 1996 outbreak.

Authors:  Jill Marturano; Lucia Fiore
Journal:  J Clin Microbiol       Date:  2002-01       Impact factor: 5.948

3.  Genomic characterization of human and environmental polioviruses isolated in Albania.

Authors:  M Divizia; L Palombi; E Buonomo; D Donia; V Ruscio; M Equestre; L Leno; A Panà; A M Degener
Journal:  Appl Environ Microbiol       Date:  1999-08       Impact factor: 4.792

Review 4.  Immunodeficiency-related vaccine-derived poliovirus (iVDPV) cases: a systematic review and implications for polio eradication.

Authors:  Jean Guo; Sara Bolivar-Wagers; Nivedita Srinivas; Marisa Holubar; Yvonne Maldonado
Journal:  Vaccine       Date:  2015-01-16       Impact factor: 3.641

Review 5.  Production of EV71 vaccine candidates.

Authors:  Pele Chong; Shih-Yang Hsieh; Chia-Chyi Liu; Ai-Hsiang Chou; Jui-Yuan Chang; Suh-Chin Wu; Shih-Jen Liu; Yen-Hung Chow; Ih-Jen Su; Michel Klein
Journal:  Hum Vaccin Immunother       Date:  2012-09-19       Impact factor: 3.452

6.  U-Omp19 from Brucella abortus Is a Useful Adjuvant for Vaccine Formulations against Salmonella Infection in Mice.

Authors:  Gabriela S Risso; Marianela V Carabajal; Laura A Bruno; Andrés E Ibañez; Lorena M Coria; Karina A Pasquevich; Seung-Joo Lee; Stephen J McSorley; Gabriel Briones; Juliana Cassataro
Journal:  Front Immunol       Date:  2017-02-17       Impact factor: 7.561

7.  Immunological evaluation and comparison of different EV71 vaccine candidates.

Authors:  Ai-Hsiang Chou; Chia-Chyi Liu; Jui-Yuan Chang; Shu-Pei Lien; Meng-Shin Guo; Hau-Pong Tasi; Kuang-Nan Hsiao; Shih-Jen Liu; Charles Sia; Suh-Chin Wu; Min-Shi Lee; Chia-Hsin Hsiao; Jen-Ren Wang; Yen-Hung Chow; Pele Chong
Journal:  Clin Dev Immunol       Date:  2012-09-12

8.  Antigenic and molecular characterization of wild type 1 poliovirus causing outbreaks of poliomyelitis in Albania and neighboring countries in 1996.

Authors:  L Fiore; D Genovese; E Diamanti; S Catone; B Ridolfi; B Ibrahimi; R Konomi; H G van der Avoort; T Hovi; R Crainic; P Simeoni; C Amato
Journal:  J Clin Microbiol       Date:  1998-07       Impact factor: 5.948

9.  Enhanced neutralizing antibody response induced by inactivated enterovirus 71 in cynomolgus monkeys.

Authors:  Hyun Ju In; Heeji Lim; Jung-Ah Lee; Sang-Rae Lee; Yeung Bae Jin; Kang-Jin Jeong; Ji-Yeon Hyeon; Jung Sik Yoo; June-Woo Lee; Young Ki Choi; Sang-Won Lee
Journal:  PLoS One       Date:  2018-10-02       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.